A number of listed companies in Shanghai and Shenzhen issued company announcements on the evening of February 16, and the following is a summary of important announcements.

[Product].

Hailanxin: It is planned to purchase 100% of the shares of Hailan Huanyu, and the stock will resume trading on the 17th

Hailanxin (300065) disclosed a major asset restructuring plan, the company intends to issue shares and pay cash, Hainan Information Industry Investment Group Co., Ltd. and other 17 counterparties, to purchase 100% of the equity of Hainan Hailan Huanyu Marine Information Technology Co., Ltd. (hereinafter referred to as "Hailan Huanyu"), and raise supporting funds, the transaction price has not yet been determined. Hailan Huanyu mainly provides maritime monitoring radar products, radar networking integrated monitoring systems and radar monitoring information services for sea-related and ground customers. After the completion of the restructuring, the company will broaden the scope of its main business and optimize its business layout. The company's shares will resume trading on February 17.

Jinli Huadian: It plans to purchase 100% of the equity of Hedlisen and add high-pressure fluid equipment business

Jinli Huadian (300069) disclosed a major asset restructuring plan, the company intends to purchase 100% of the equity of Beijing Hydelisen Technology Co., Ltd. (hereinafter referred to as "Hydelison") by issuing shares and paying cash, and intends to issue shares to the company's controlling shareholders to raise matching funds, the transaction price has not yet been determined. Hedlisen is mainly engaged in the research and development, production and sales of high-pressure fluid equipment. After the completion of the transaction, the company will add a new high-pressure fluid equipment business segment. The company's shares will resume trading on February 17.

Jiaoda Onlly: Disclosed the results of the tender offer to acquire the company's shares, and the stock resumed trading on the 17th

Jiaoda Onlly (600530) announced that previously, Shanghai Decoration Design Engineering Co., Ltd. (hereinafter referred to as "Shanghai Decoration") issued a partial offer, and the number of shares of the company accounted for 5% of the company's total share capital. As of February 13, the tender offer expired. During the tender offer period, the total number of pre-offered shareholder accounts is 23, and the total number of pre-offered shares is 532,600 shares, accounting for 0.07% of the company's current total shares. After the completion of the tender offer, Shanghai Decoration and its concert parties hold a total of 30.06% of the company's shares. The company's shares resumed trading on February 17.

Xinshida: The actual controller will be changed to Haier Group, and the company's shares will resume trading on the 17th

Xinshida (002527) disclosed the progress of the transfer of control of the company: on February 14, Qingdao Haier Kaos Industrial Intelligence Co., Ltd. (hereinafter referred to as "Haier Kaos Industrial Intelligence") signed a share transfer agreement, a voting rights entrustment agreement and a concerted action agreement with Ji Defa, Liu Liping and Ji Yi, stipulating that Ji Defa and others would transfer a total of 10% of the company's shares to Haier Kaos Industrial Intelligence, and irrevocably entrust the voting rights enjoyed by the company's 19.24% shares to Haier Kaos Industrial Intelligence. And determine the concerted action relationship between Haier Kaos Industrial Intelligence and Ji Defa, Liu Liping and Ji Yi. Through the transfer of agreements, voting rights entrustment and concerted action arrangements, Haier Kaos Industrial Intelligence will control the voting rights corresponding to 29.24% of the company's shares in total, and become the controlling shareholder of the company, and Haier Group will become the actual controller of the company. In addition, Haier Kaos Industrial Intelligence intends to subscribe for 153 million shares issued by the company to specific targets. After the completion of the issuance, Haier Kaos Industrial Intelligence will directly hold 219 million shares of the company, accounting for 26.83% of the company's total share capital after the issuance. The company's shares resumed trading on February 17.

Hongsheng Huayuan: China Electric Equipment will become the direct controlling shareholder of the company

Hongsheng Huayuan (601096) announced that in order to further straighten out the equity relationship and optimize the equity structure, the company's indirect controlling shareholder, China Electrical Equipment, signed the "Share Transfer Agreement" with Shandong Electric Electric, which intends to transfer 31.52% of the company's shares held by Shandong Electric to China Electrical Equipment free of charge. After the completion of the free transfer, China Electric Equipment will become the direct controlling shareholder of the company. The actual controller of the company is still the State-owned Assets Supervision and Administration Commission of the State Council.

Chongqing Gas: A special rectification and supervision team has been dispatched to address the problem of gas charging

Chongqing Gas (600917) announced that on February 14, the Chongqing Municipal Market Supervision and Administration Bureau notified the investigation of the company's gas charges. In response to the reported problems, the higher-level units attach great importance to it and have dispatched a special class for rectification and supervision. The company will complete the rectification work as soon as possible and effectively safeguard the rights and interests of the majority of users. At the same time, the relevant responsible persons and responsible departments will be seriously held accountable.

Runjian Co., Ltd.: The company has not signed a service cooperation agreement with DeepSeek

Runjian Co., Ltd. (002929) issued an announcement on stock trading changes, saying that the company's self-developed "Quqi" artificial intelligence open platform docks and deploys the DeepSeek series of models, empowering the company's internal digital and intelligent transformation and helping the development of AI application business. However, the company has not signed a service cooperation agreement with DeepSeek, and there is no business cooperation with it, and the impact of this matter on the company's future performance is uncertain.

[Performance].

FAW Jiefang: Automobile sales in January were 22,400 units, a year-on-year decrease of 28.35%.

FAW Jiefang (000800) announced that in January 2025, the company's automobile sales will be 22,400 units, a year-on-year decrease of 28.35%.

[Miscellaneous].

Sinovel Precision: The application for issuing shares to specific targets was approved by the China Securities Regulatory Commission for registration

Huarui Precision (688059) announced that the company recently received an approval from the China Securities Regulatory Commission to approve the company's registration application for issuing shares to specific objects.

CR Shuanghe :D C50292A tablets were approved for clinical trials

China Resources Shuanghe (600062) announced that Shuanghe Runchuang, a wholly-owned subsidiary of the company, recently received the approval notice for clinical trials of DC50292A tablets of drugs issued by the State Food and Drug Administration. DC50292A tablets are intended for the treatment of patients with advanced solid tumors, and are Class 1 new drugs that have not been marketed at home or abroad.

Rhine Biotech: Enzyme-transgenic steviol glycoside RebM2 has passed the GAS CERTIFICATION OF THE US FDA

Rhine Biotech (002166) announced that recently, the company received a certification notice from the U.S. Food and Drug Administration (FDA), and the company's enzyme-transsteviol glycoside RebM2 officially passed the GRAS (Generally Recognized as Safe English abbreviation, Generally Recognized as Safe) certification, which can be used as a food additive and dietary supplement, marking that the product has the access conditions to enter the U.S. food and beverage market.

Hengrui Pharmaceutical: The marketing authorization application for imaxitinib ointment was accepted

Hengrui Pharmaceutical (600276) announced that recently, the company received a notice of acceptance issued by the State Food and Drug Administration, and the marketing authorization application for imaxitinib ointment submitted by the company was accepted by the State Food and Drug Administration. The drug is indicated for topical treatment of mild to moderate atopic dermatitis in adults.

Warner Pharmaceutical: A wholly-owned subsidiary passed the drug GMP compliance inspection

Huana Pharmaceutical Co., Ltd. (688799) announced that recently, the company's wholly-owned subsidiary, Chiral Pharmaceutical Co., Ltd., received the drug GMP compliance inspection notice issued by the Hunan Provincial Food and Drug Administration, and its two API varieties such as ipratropium bromide and dimethicone in Wangcheng District, Changsha City have passed the drug production quality standard compliance inspection (i.e., drug GMP compliance inspection), marking that the chiral drug company can officially produce and sell the above API products.